key: cord-1032696-h99ar31v
authors: Heydari, Zahra; Moeinvaziri, Farideh; Agarwal, Tarun; Pooyan, Paria; Shpichka, Anastasia; Maiti, Tapas K.; Timashev, Peter; Baharvand, Hossein; Vosough, Massoud
title: Organoids: a novel modality in disease modeling
date: 2021-08-09
journal: Biodes Manuf
DOI: 10.1007/s42242-021-00150-7
sha: b9d7992c6c352c9ab67f4475b1fd32cc69dfe1e7
doc_id: 1032696
cord_uid: h99ar31v

Limitations of monolayer culture conditions have motivated scientists to explore new models that can recapitulate the architecture and function of human organs more accurately. Recent advances in the improvement of protocols have resulted in establishing three-dimensional (3D) organ-like architectures called ‘organoids’ that can display the characteristics of their corresponding real organs, including morphological features, functional activities, and personalized responses to specific pathogens. We discuss different organoid-based 3D models herein, which are classified based on their original germinal layer. Studies of organoids simulating the complexity of real tissues could provide novel platforms and opportunities for generating practical knowledge along with preclinical studies, including drug screening, toxicology, and molecular pathophysiology of diseases. This paper also outlines the key challenges, advantages, and prospects of current organoid systems. [Image: see text]

Shedding light on the cellular and molecular pathophysiology mechanisms of diseases is a principal goal for scientists. Over the years, existing knowledge of the human system and its dynamics have developed from the examination of post-mortem and pathological specimens to animal models [1] . The latter add significant value while presenting many challenges, including high time and monetary costs, ethical concerns, and most importantly, they fail to accurately predict the clinical efficacy of therapeutics due to different pharmacokinetics, pharmacodynamics, and interspecific genetic or metabolic variations [1, 2] (Fig. 1 ). In addition, few human tissues are accessible for investigation and analysis. As a result, many gaps need to be addressed for a detailed knowledge of human development and disease-related events.

A major recent advancement in 3D culture was the generation of 3D structures called 'organoids' [3] . The term 'organoid' was first used in the literature in 1946 when Smith and Cochrane described a cystic teratoma [4] . Nowadays, organoids are defined as systems originating from either pluripotent stem cells (ESCs or iPSCs) or neonatal/ adult stem/progenitor cells, both with the potential to selforganize into in vivo-like organ complexes and the ability to recapitulate essential organ functions (Fig. 2) [1, 3, 5] . In the process of organoid generation, extracellular matrix (ECM) and medium signaling are essential for facilitating cell-cell interactions-these are integral to self-assembly and cellular and animal models, which make them a practical platform for different experiments, modeling diseases, and high-throughput screening differentiation [1, 6] . Consequently, by acting as accurate human disease models, organoids have paved the way for discoveries in human biology and have advanced medical care by providing a platform for drug screening (Fig. 3) .

In drug discovery processes, in order to obtain a single approved drug, tens of thousands of the new compounds need to pass several screening stages before being considered as Investigational New Drugs (INDs) for further evaluation and subsequent clinical trials. This process is lengthy and expensive, though most (about 80%) approved agents still fail during clinical trials [7] . Thus, organoids can significantly facilitate drug testing. To date, organoid models of microcephaly, cystic fibrosis, ulcerative colitis, and Crohn's disease have already helped develop new pharmaceuticals for these diseases [8, 9] . Besides, organoids can also act as cancer models; however, it is important to note that primary cancer-derived organoids face unique challenges, including the lack of tissue structure and extensive heterogeneity with no tumor microenvironment, and consequently the inability to model localized hypoxia and the input from surrounding immune cells [10] (Box 1). This review highlights diseases of different germ layers modeled using distinct organoid structures, including the neuronal, hepatic, and renal tissue (Fig. 3 ). In addition, due to the current COVID-19 pandemic, we have also included descriptions of organoid models that simulate tissue-specific responses to COVID-19 (Box 2).

The in vitro modeling of human brain development was performed using embryoid body (EB) cultures. In 2001, human ESCs were used to generate EBs that could form 2D rosettelike structures after an initial phase of 3D culture [45] . This revealed that EBs could generate clusters of neuroepithelial cells that self-organized into neural tube-like structures [46] . The rosette formations were generated by extending the time spent in the initial 3D culture phase before plating on precoated dishes; this technique generated complex stratified structures reminiscent of the developing cerebral cortex [46] [47] [48] [49] [50] [51] [52] . Building on these findings, an in vitro system for the generation of brain-like organoids was developed in 2013 to generate a broader brain region identity termed 'cerebral organoids' [53] . Subsequently, various brain organoid protocols have been introduced over the past few years, all describing different techniques to generate brain organoids that closely mimic the brain as an organ.

Currently, brain organoid models open up the prospect of answering many questions regarding different brain diseases and developmental disorders (Table 1) . A study reported using iPSC-derived organoids from patient with microcephaly, a genetic condition caused by a mutation in a gene Different protocols to generate tissue-specific and pluripotent stem-cell-derived organoids. Organoids can be generated from tissuespecific sample biopsies from a variety of organs, or from pluripotent stem cells. The figure illustrates different protocols to induce the maturation and formation of organoids, such as matrix embedding, suspension, using U bottom cell culture plates, and so on. Abbreviations: ASPC, adult stem or progenitor cell; PSC, pluripotent stem cell encoding the CDK5 regulatory subunit-associated protein 2 (CDK5RAP2). Microcephalic patients have a reduced brain size, and this condition is challenging to model using mice [53] . Another study described the use of human Seckel iPSC-derived organoids developed to model Seckel syndrome, which is caused by a mutation in the centrosomal P4.1-associated protein (CPAP) leading to a reduction in the human brain size as well as reduced pre-and postnatal body size. Organoids derived from patient iPSCs with mutated CPAP failed to provide a scaffold for the cilium disassembly complex (CDC) and thus led to premature cellular differentiation in a study, which demonstrated many unknown features of neural progenitor cell differentiation that are important in the mechanism of microcephaly development [54] . To Human organoids are crucial players in the pursuit of advancement in cancer biology studies, to improve preclinical studies and to facilitate their translation into effective therapies. Previously, human cancer cell lines, mouse cancer models or patient-derived xenografts (PDXs) consisted the main platform for cancer research and drug discovery [11, 12] . Nowadays, with the advent of adult stem cell-derived organoid technology, cancer tissues have been cultured in vitro as cancer organoids, also known as tumouroids or canceroids. As such, cancer organoids can be derived directly from the tumor tissue of any individual, providing an attractive ex vivo platform to study human cancer biology [11] [12] [13] . Cancer organoid models are valuable for recapitulating the human tumor biology, as well as the interactions between neoplastic cells with extracellular matrix, immune cells and tumor vasculature. Additionally, cancer cells can generally grow independently of the niche factors when compared with non-cancerous organoids [11] . Patient samples from colon [14] [15] [16] [17] [18] , esophageal [19] , stomach [20] [21] [22] , brain [23, 24] , prostate [13] , pancreas [25] [26] [27] , liver [28] , breast [29] , bladder [30] , endometrial [31] and lung [32, 33] cancers have been cultured in cancer organoid models. In a recent analysis of drug responses in patients, organoid cultures were matched with the patient response up to 90% [34] . Remarkably, Hans Clevers and colleagues recently established tumor organoid cultures from colorectal cancer and called them 'living organoid biobanks' [14] . These living biobanks of canceroids from gastrointestinal cancers recapitulated the patient response to anti-cancer agents in clinical trials [34, 35] . Altogether, an increasing number of patient-derived canceroids have provided unprecedented access to cancer medicine. In this regard, patient-derived organoid models of the future may provide an in vitro screening platform to predict the best therapeutic option for each individual, to model genetic cancer progression in a better physiological platform, and to study a tumor niche that represents the different grades of tumors this end, Li et al. reported that cortical organoids generated from patient-specific iPSCs with the dysfunction of Aspm gene, a further genetic cause of primary microcephaly in humans, were unable to form normal cortical lamination [55] . Finally, the authors of another study demonstrated that the CRISPR/Cas9 deletion of PTEN, a gene associated with human macrocephaly, resulted in the proliferation of neuronal stem cells, and cerebral organoids were created that were more folded and had larger overall mass than normal cerebral organoids [56] . Human brain organoid models of early brain development are invaluable for the study of psychiatric conditions. In 2015, iPSC lines from four patients with severe autism spectrum disorder (ASD) were produced, and the subsequently grown patient-derived organoids exhibited more inhibitory GABAergic neurons due to an upregulation of the forkhead box G1 (FoxG1) gene [57] . Furthermore, chromodomain helicase DNA-binding protein 8 (CHD8) is a commonly mutated gene in ASD; CHD8 +/− cerebral organoids were generated by Wang et al. using CRISPR-Cas9 technology. The authors established that CHD8 regulates the expression of other genes implicated in ASD, including the downstream signaling molecule associated with DLX6-AS1, which is a long non-coding antisense RNA. DLX6-AS1 critically regulates GABAergic interneuron development and is likely to prove important in therapeutics approaches [58] . The 'disrupted-in-schizophrenia 1' gene (DISC1) interacts with other proteins to influence human brain development, and its mutations are related to numerous psychiatric disorders, such as schizophrenia, bipolar disorder, and autism spectrum disorders. Disrupting the formation of DISC1/Ndel1 complex resulted in cell-cycle deficits in radial glial cells within human forebrain organoids, and the same disruption was observed in organoids derived from iPSCs of schizophrenic patients [59] . Rett syndrome (RTT), another neurodevelopmental disorder, is caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene, which is a gene that influences miRNA expression. The MECP2 gene has also been linked to neuropsychiatric disorders including ASD. Patient-derived cerebral organoids from Rett patients demonstrate the effects of MeCP2 deficiency on human neurogenesis and neuronal differentiation and were used to validate the involvement of a novel miRNA-mediated pathway in ASD [60] . Sandhoff disease, a lysosomal storage disorder, which is also known as GM2 gangliosidosis, was modeled in cerebral-specific organoids using iPSCs derived from an infant carrier of this mutation. The diseased organoids had enlarged size with increased cellular proliferation and displayed accumulated GM2 ganglioside, supporting the idea that GM2 ganglioside accumulation alters early neurodevelopmental processes with downstream postnatal effects [61] .

Brain organoid technology has led to the discovery of many human brain-specific phenotypes. Two papers have used brain organoids to model a severe genetic condition named Miller-Dieker syndrome (MDS) associated with lissencephaly ('smooth brain'). Mice are naturally lissencephalic and cannot be used to model this defect [62, 63] ; therefore, human organoids have enormous potential in elucidating the pathophysiology of this condition.

Zika virus (ZIKV) infection is yet another cause of congenital microcephaly. ZIKV-infected human brain organoids demonstrate delay in the cell cycle progression of neural progenitor cells, leading to cell death and the smaller size of infected organoids, thus mimicking microcephaly [64] [65] [66] . The innate immune receptor 'Toll-like receptor 3' (TLR3) was found to be upregulated after ZIKV infection, which Box 2 Current organoid models for COVID-19

Due to the inadequate knowledge of the biology of SARS-coronavirus 2 (SARS-CoV-2) that causes the current COVID-19 pandemic, the therapeutic options are limited. Therefore, it is of great importance to construct new disease models to study the biology of SARS-CoV-2 and provide a practical platform for drug screening studies. In one study, human recombinant soluble angiotensin-converting enzyme 2 (hrsACE2) reduced the growth rate of SARS-CoV-2. It was also shown that SARS-CoV-2 can directly infect bioengineered human blood vessel organoids and human kidney organoids, which can be inhibited by hrsACE2. These results demonstrated that hrsACE2 can significantly block the early stages of SARS-CoV-2 infection [36] [37] [38] and highlighted its potentially enormous clinical application. Researchers established a human liver ductal organoid to model hepatic infection by SARS-CoV-2, and thus validated viral-induced damage of cholangiocytes ex vivo at the cellular and molecular levels. It was demonstrated that viral infection damages the barrier and bile acid transporting functions of cholangiocytes due to dysregulation of the genes directly involved in tight junction formation and development, as well as bile acid transportation. Thus, liver damage in patients with COVID-19 might be a direct result of cholangiocyte injury and bile acid accumulation [39] . Respiratory symptoms are typical in COVID-19 patients, however, 25% of such patients present gastrointestinal signs/symptoms including anorexia, diarrhea, vomiting, and abdominal pain [40] . ACE2 acts as a SARS-CoV-2 receptor for the viral S protein, which is expressed in a variety of human tissues, including the testis, kidneys, gut, and lungs [41, 42] . It is mainly expressed in the alveolar epithelium type II cells and ciliated cells of lungs, but also has high expression within the brush border of intestinal enterocytes [43] . Recently, a colon model was generated using human pluripotent stem cell-derived colonic organoids (hPSC-COs) to explore the permissiveness of colonic cell types to SARS-CoV-2 infection. Results indicated that, although ACE2 is expressed in all of the hESCderived colonic cell types, its expression is significantly higher in enterocytes. The COs have also been used in high-throughput drug screening studies of 1280 FDA-approved drugs in viral infection treatments. Remarkably, results indicated that two drugs (mycophenolic acid and quinacrine dihydrochloride) were able to block viral infection in the gut [40] . Finally, human small intestinal organoids have also been generated and shown to support SARS-CoV-2 replication within infected enterocytes [44] The role of p25/Cdk5 was validated in tauopathy. Additional efforts to develop inhibitors of p25-mediated Cdk5 dysregulation could benefit patients

Matrigel suspension [80] Aβ accumulation, tau aggregates, and cellular apoptosis reported as hallmark features of AD were observed in the generated model, which offers a new platform for drugs screening for therapeutic intervention None [81] Neurons, astrocytes, microglia A 3D human AD model was introduced by using neurons, astrocytes, and microglia in a microfluidic system. A more precise human brain model was presented to understand the neural-glial interactions and for drug discovery Matrigel embedding [82] Parkinson's disease iPSC An organoid-based model recapitulating the pathological hallmarks of LRRK2associated with sporadic PD was presented, which aids the advance of therapeutic discovery

Matrigel embedding [83] Reduction in dopaminergic neurons and increase of FOXA2 was observed in patient-derived organoids, which contained midbrain dopaminergic neurons for investigating the pathogenesis of the disease None [84] Differences in the expression levels of LIM homeobox transcription factoralpha and tyrosine hydroxylase markers between organoids from diseased patients and healthy individuals was observed. This provides a model for studying the cellular interactions within the human brain

Matrigel suspension [85] led to alterations in gene expression patterns and the disruption of physiological neurogenesis. Interestingly, the inhibition of TLR3 improved the pathological phenotype of ZIKV-infected human brain organoids [67] . Research using a model of the developing brain based on embryonic stem cell-derived brain organoids indicates that prenatal ZIKV infection may alter the DNA methylation pattern in the entire genome of neuronal cells, resulting in brain diseases later in life [68] . Zhou et al. indicated that hippeastrine hydrobromide (HH) improved cellular growth and differentiation in ZIKV-infected human fetal-like forebrain organoids [69] .

To model the effects of ZIKV, Watanabe et al. described brain organoids that were able to develop cortical and basal ganglia structures similar to the human fetal brain and identified new potential receptors for ZIKV entrance to neural progenitors [70] . Sacramento et al. showed the potential of sofosbuvir, an anti-hepatitis C virus (HCV) drug, to block ZIKV replication in hepatoma cells, neuroblastoma cells, neural stem cells, and brain organoids [71] . By performing a drug repurposing screening of about 6000 compounds, Xu et al. identified two classes of effective compounds (neuroprotective and antiviral) that could be used in combination to protect human neural progenitors and astrocytes from ZIKV-induced cell death [72] . Li et al. highlighted the role of cholesterol-25-hydroxylase (CH25H) as a natural antiviral agent during ZIKV infection, in that it reduced ZIKV-mediated tissue damage in human cortical organoids [73] . Overall, these Zika-infected brain organoid models were applied successfully to test the efficacy of different treatment strategies for Zika virus infection. However, the apparent contradiction in findings suggests that organoid models require further development and should be used in combination with other models to improve disease modeling and drug discovery [74] [75] [76] [77] [78] .

Due to the immaturity of neurons derived in vitro, it remains unclear how much knowledge on neurodegenerative diseases may be acquired from human iPSC-derived organoid models. The first study that used human brain organoids to investigate Alzheimer's disease (AD), published in 2016, developed a scaffold-free culture method to generate brain organoids derived from multiple patients with familial AD (FAD). These FAD-generated organoids reproduced numerous AD-like pathologies, such as amyloid aggregation, hyperphosphorylated tau protein accumulation, and endosome abnormalities. Furthermore, they showed that the patient-derived organoids treated with β-and γ-secretase inhibitors exhibited significantly reduced amyloid formation and tau pathology [79] . To validate the role of p25/Cdk5 in tauopathy, a cerebral organoid model was developed from isogenic iPSCs and was used to demonstrate that the blockade of p25 mediates tau-associated pathology and the increased expression of synaptophysin [80] . A sophisticated AD model was generated from human iPSCs derived from AD-affected patients with Down syndrome. Cells within this model exhibited Aβ accumulation, tau aggregates, and cellular apoptosis, all hallmark features of AD [81] . Park et al. presented a new 3D human AD tri-culture of neurons, astrocytes, and microglia within a microfluidic system, which was able to model important features of AD, including Aβ aggregation, phosphorylated tau accumulation and neuroinflammatory activity, as well as axonal cleavage resulting from neurotoxic activities. This study has facilitated the understanding of neural-glial interactions and AD drug discovery [82] .

Parkinson's disease (PD) is another common neurological disorder; in one study, midbrain organoids were developed from iPSCs exhibiting the Parkinson's disease-associated LRRK2 G2019S mutation. These organoids recapitulated the pathological hallmarks of LRRK2-associated sporadic PD and offered great potential for screening targeted therapies for patients with this disease [83] . In a separate study, midbrain organoids derived from PD patients carrying the LRRK2-G2019S mutation exhibited a reduced number and complexity of midbrain dopaminergic neurons and increased expression of FOXA2 (required for midbrain dopaminergic neuron generation), when compared to the control organoids [84] . Recently, an organoid model of idiopathic PD was developed from the iPSCs of patients with idiopathic PD. Compared with their healthy counterparts, the created mature and multicellular organoid-like structures displayed significant differences in the expression levels of neuronal markers, including LIM homeobox transcription factor-alpha and tyrosine hydroxylase expression [85] . Mature midbrain-like organoids (MOs) with a homogeneous distribution of neurons have also been generated. These MOs contain multiple neuronal subtypes, including midbrain dopaminergic neurons. Interestingly, midbrain astrocytes undergo massive cell death in the generated organoids upon treatment with astrocyte-mediated dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), an agent known to cause PD [86] .

The results of the above studies show that human brain organoids might provide an efficient drug discovery platform for brain-related diseases.

During embryonic development, the inner ear arises from a thickening of the surface ectoderm adjacent to the hindbrain. The simple thickened epithelium deepens to form an otic vesicle. Otic vesicles develop into the mature inner ear structure in response to specific morphogenetic events and inductive interactions with surrounding tissues [87, 88] . The first inner ear organoid was generated in 2013 [89] , and the first report of an inner ear disease organoid model was published in 2019 [90] ( Table 1 ). The type II transmembrane protease 3 (TMPRSS3) is required for proper mammalian hearing, and mutations in TMPRSS3 cause congenital and early-onset hearing loss in humans. The exact mechanism of this process is unknown; however, mouse stem cell-derived inner ear organoids recently used to investigate the underlying mechanisms of TMPRSS3-related hearing loss or deafness revealed that TMPRSS3 is a crucial component for hair cell homeostasis, and its mutations induce hair cell apoptosis and degeneration [90] .

Retinal organoids can recapitulate the spatiotemporal differentiation of the retina and have proven as effective models for understanding retinal development and diseases, as well as drug screening tools [91] . Retinal tissue 3D organoids were first generated in their entirety from mouse cells in 2011 and from human embryonic stem cells in 2012 [92, 93] (Table 1) . Several such organoids have been described to date. Leber Congenital Amaurosis (LCA) is a disease of the retina that leads to hereditary blindness. Parfitt et al. generated LCA-retinal organoid models from iPSCs exhibiting a common mutation in the cilia-related gene CEP290. The grown organoid cells were able to form an optic cup structure but exhibited decreased ciliation and reduced cilium length. Normal cilium length and ciliary trafficking returned after treatment to restore the expression of fulllength CEP290 [94] . X-linked retinitis pigmentosa (XLRP) is a rare genetic eye disease caused by mutations to the Retinitis Pigmentosa GTPase Regulator (RPGR). In one study, significant defects in the photoreceptor were observed in patient-specific organoid models generated from three retinitis pigmentosa patients harboring RPGR mutations. However, the CRISPR-Cas9 correction of the RPGR mutation rescued both photoreceptor structure and electrophysiological properties [95] . In a different study, retinal organoids generated from a patient carrying the Retinitis Pigmentosa 2 (RP2) nonsense mutation revealed that the loss of Kif7 at the cilia tips in iPSC-derived 3D optic cup photoreceptors was rescued by translational read-through inducing drugs, such as PTC124 [96] . Late-onset RP is more challenging to model than early-onset RP, while one study successfully developed retinal organoids from late-onset RP proband-derived iPSCs harboring the PDE6B mutation. These organoids were able to recapitulate the late-onset disease phenotype and thus provided new insights into the PDE6B-related mechanism of RP [97] .

The human skin has a surface area of almost 2 m 2 in adults and acts as an important physical barrier protecting the internal environment from outside pathogens. In vitro human skin organoid models are expected to be useful for studying the mechanisms of hair follicle induction, inhibition, and modeling (Table 1) . One study generated an organoid model from systemic sclerosis (SSc)-derived iPSCs by inducing their differentiation into keratinocytes and fibroblasts. SSc is a rare autoimmune disease characterized by skin fibrosis, featuring the excessive production and accumulation of collagen in the skin. Patient-derived skin organoids exhibit the classic characteristics of SSc skin cells, which highlights their importance as drug screening tools [98] . Atopic eczema (also known as 'atopic dermatitis' or 'eczema') is an itchy inflammatory skin disorder involving mutations to the gene encoding filaggrin (FLG). Recently, organoids derived from primary human keratinocytes with and without siRNAmediated knockdown of FLG have been used to elucidate the mechanisms by which FLG haplo-insufficiency leads to atopic inflammation [99] .

Drug development for cardiovascular diseases is challenged by a limited supply of tissue samples and appropriate in vitro culture conditions. Meanwhile, 3D cardiac organoids can help create new physiological models of cardiovascular diseases (Table 2) .

Barth syndrome (BTHS) is a mitochondrial disorder caused by the mutation of Tafazzin (TAZ). Patient-derived iPSCs and a microchip were used to create BTHS organoid models that replicated the pathophysiology of BTHS cardiomyopathy and helped derive a new therapeutic strategy for BTHS [100] . Dilated cardiomyopathy (DCM) is a major cause of heart failure and premature death and is characterized by progressive left ventricular dilation and systolic dysfunction. The most common genetic causes of DCM are mutations resulting in the truncation of the sarcomere protein titin (TTNtv). Cardiac organoids derived from titin-mutated iPSCs have highlighted how the inadequate generation of sarcomeres impaired tissue responses to mechanical and β-adrenergic stress, likely causing DCM [101] . Hypertrophic cardiomyopathy (HCM) leads to sudden cardiac death. The first 3D human engineered cardiac tissue model for HCM was created using cells from a patient with cardio-facio-cutaneous syndrome (CFCS), a syndrome that is characterized by genetic mutations to any of MEK1 or MEK2 or BRAF genes. A 3D in vitro disease model was constructed from BRAF-mutant cells using a combination of tissue engineering and iPSC technology, which was able to mimic the key features of HCM associated with CFCS. This new in vitro model has the Matrigel sandwich [106] The model highlighted the importance of podocalyxin in microvillus assembly, and provided a powerful tool for studying human kidney regeneration GelTrex [114] PSCs A human cellular system was established by combining polycystic kidney disease organoids with physical components. This approach provided a model of polycystic kidney disease Matrigel embedding [108] potential to screen for new therapeutic approaches to treat this and related heart conditions [102] . Missense mutations in the regulatory subunit PRKAG2 activate AMPactivated protein kinase (AMPK), and this process mimics some features of HCM. To model this type of cardiomyopathy, myocytes differentiated from patient-derived iPSCs were combined into 3D cardiac micro-tissues. The model highlighted essential connections between metabolism and transcript regulation with a better outlook for understanding the AMPK function and the mechanism of PRKAG2 cardiomyopathy [103] . In acute myocardial infarction (AMI), cardiomyocytes die due to ischemia. The process of AMI was modeled using human cardiac-derived organoids exposed to local tissue damage using cryoinjury by dry ice. Interestingly, the organoids displayed tissue regeneration over a period of 2 weeks after acute injury [104] . Duchenne muscular dystrophy (DMD) is associated with the lethal degeneration of cardiac and skeletal muscle. To explore the therapeutic value of gene editing to bypass the metabolic abnormalities in DMD cardiac contractility, Long et al. generated 3D DMD-engineered heart muscles (DMD-EHM) from human iPSCs. The authors used the gene editing of heart muscle cells to repair the contractile dysfunction in DMD-EHM organoids [105] . These achievements highlight the value of organoid technologies and the means by which developments in human cardiac disease organoid models may facilitate cardiac drug discovery.

Recent work has incorporated genome editing tools into patient iPSC-derived kidney organoids, thus providing a unique opportunity to study human kidney diseases with a precise control of the genetic background (Table 2) . Freedman et al. described a human model for polycystic kidney disease (PKD) where the knockout of polycystic kidney disease-related genes PKD1 or PKD2 by CRISPR/Cas9 led to cysts forming in kidney tubules. The authors further showed that podocalyxin gene (PODXL)-defective kidney organoids have junctional organization defects in podocytelike cells, and hiPSC-derived podocyte cells might have the potential to recapitulate the glomerulopathies involved in the podocyte epithelium injury [106] . In a follow-up study, lossof-function mutations in the human PODXL gene (PODXL knockout hiPSC-derived podocytes) were shown to cause defects in microvillus assembly, leading to increased space between podocytes and in turn the formation of porous junctions, highlighting the importance of podocalyxin in microvillus assembly [107] . By culturing mutant kidney organoids in suspension culture, Freedman and colleagues established an efficient model of PKD cystogenesis, in which the cysts of The nephrotic syndrome was reconstructed using iPSC-derived kidney organoids. This new approach revealed the initial phase of podocyte abnormalities None [111] Nephronophthisis-related ciliopathy (NPHP-RC)

The tubular epithelia of probandderived organoids featured shortened and club-shaped primary cilia. This model established the common pathogenic mechanisms for this rare heterogenetic disease

Matrigel suspension [112] Coronavirus disease 2019 hESC Clinical grade hrsACE2 reduced SARS-CoV-2 recovery of Vero cells by a factor of 1000-5000; an equivalent mouse rsACE2 had no effect Vitronectin [115] PKD patients were recapitulated. The PKD2−/− organoids were defective in expressing of the polycystin-1 protein, and the knockdown of polycystin-2 protein also decreased polycystin-1 protein expression. These mutations altered organoid ECM remodeling and thus emphasized the importance of the ECM in maintaining tubular architecture and adhesion forces for cystogenesis [108] . Hale et al. grew organoid glomeruli from a congenital nephrotic syndrome patient (organoid-derived glomeruli, OrgGloms), which exhibited lower expression levels of PODOCIN and NEPHRIN. These proteins are uniquely expressed in the kidney and are involved in the structure of filtration slits of podocytes and renal filtration barrier function, respectively. Thus, this organoid model represents an accessible approach for modeling human podocytopathies, screening podocyte toxicity, and exploring drug efficacy [109] . Low et al. established an in vitro model from autosomal recessive PKD patient-derived hiPSCs. Notably, mutant organoids showed a cystic phenotype, a characteristic PKD feature, which could be prevented by gene correction or drug treatment [110] . Mutations in the NPHS1 gene causes congenital nephrotic syndrome resulting in an impaired slit diaphragm (SD) formation. The kidney organoids generated from a patient with an NPHS1 missense mutation were used to reveal the initial phase of podocyte abnormalities [111] . Reprogramming and gene editing protocols were used to derive both proband-derived iPSCs and isogenic gene-corrected iPSCs for generating kidney organoids. The organoid generated from proband-derived iPSCs presented a nephronophthisis-related ciliopathy (NPHP-RC), and interestingly, the tubular epithelium of proband organoids were shortened, club-shaped primary cilia [112] .

Although the kidney has a complex structure and intricate functions, new methods to model kidney disease using organoids and in turn facilitate our understanding of pathobiology and drug discovery are emerging.

The lung epithelium derived from the endodermal germ layer undergoes a complex series of endoderm-mesodermmediated signaling events to develop into the final arborized network of conducting airways (bronchi, bronchioles) and gas-exchanging units (alveoli). The alveolar surfaces are lined by alveolar type 1 (AT1) and alveolar type 2 (AT2) epithelial cells. The covering epithelium of airways and alveoli faces several inflammatory conditions and progressive diseases, including idiopathic pulmonary fibrosis (IPF), bronchial asthma, chronic obstructive pulmonary disease, and respiratory infections such as those by coronavirus and influenza [116] (Table 3 ).

The first successful organoid model for lung epithelial cells was developed by McQualter et al. using stem/progenitor cells in the presence of fractionated primary mouse lung stromal cells [117] . Wilkinson et al. generated an IPF model using human iPSC-derived mesenchymal cell organoids, which were treated with TGF-β to induce fibrosis [118] . Strikoudis et al. developed ESC-derived organoids using CRISPR/Cas9 to introduce frameshift mutations in Hermansky-Pudlak syndrome (HPS) genes. The clinical features of this syndrome were similar to IPF. Genome-wide expression analysis revealed the upregulation of interleukin-11 (IL-11) in the epithelial cells of HPS mutant fibrotic organoids. Notably, IL-11 functioned as a fibrosis inducer in wild-type (WT) organoids, while the IL-11 deletion prevented fibrosis in HPS4−/−. These data suggest that IL-11 is a therapeutic target and a promising molecule to facilitate fibrosis-associated lung disease modeling [119] . Using 3D lung organoids from patients with IPF, Surolia et al. demonstrated that the inhibition of vimentin intermediate filaments (VimIFs) decreased the invasiveness of IPF fibroblasts and conferred protection against fibrosis in a murine model of experimental lung injury [120] .

Viral infections of the distal lung parenchyma can progress from pneumonia to acute respiratory distress syndrome. Recent developments in multicellular and physiologically active organoid cultures derived from PSCs, as well as stem cells isolated from biopsies, have opened up horizons to better understand microbial pathogenesis and host-microbe interactions [121] . Cryptosporidium, a protozoan parasite, is a primary cause of diarrhea and a major culprit of child mortality worldwide, though no relevant experimental culture system to facilitate drug development has yet been constructed. In a recent study, epithelial organoids were established derived from the human small intestine and lungs, and were infected with Cryptosporidium. The results indicated that Cryptosporidium could replicate and complete its entire life cycle within these organoids [122] . Infections with a different pathogen, the influenza virus, represent a major global public health threat. Zhou et al. developed long-term expanding human airway organoids (AO) composed of four types of airway epithelial cells: ciliated, goblet, club, and basal cells. These AOs exhibited physiological phenotypes including beating cilia and elevated serine protease levels crucial for the productive infection of human influenza viruses [123] . One study established human stem cell-derived airway organoids with similar morphological characteristics to human airways, including mucus-secreting goblet cells, club cells, and ciliated epithelial cells with active ciliary beating and mucus movement over the epithelial surface. These organoids served as a platform to compare the viral replication capability, tissue tropism, as well as cytokine and chemokine induction of avian influenza A viruses isolated from humans (types Sh2/H7N9, H5N1/483, [142] iPSC-HLC, MSCs and HUVEC The model featured high-level expression of NTCP and showed well-maintained long-term HBV propagation, which was associated with hepatic dysfunction None [143] Coronavirus disease 2019

Cholangiocytes Viral infection damaged the bile acid transport in cholangiocytes due to dysregulation of genes involved in tight junction development and bile acid transportation

Matrigel embedding [39] Wolman disease Patient-derived iPSCs Treatment with FGF19 increased the survival rate in the culture system and reduced lipid accumulation, ROS production, and stiffening

Matrigel embedding [136] A1AT deficiency Patient-derived Lgr5 + liver stem cells A1AT accumulation was similar to the original biopsies from patients, and the aggregation of A1AT protein blocked elastase activity in A1AT organoids

Matrigel embedding [145] Alagille syndrome Structural duct defects in the biliary tree were simulated

Matrigel embedding [145] iPSC-derived cholangiocytes and hepatocytes

The JAG1 mutation in Alagille syndrome was studied using this organoid model

Matrigel embedding [146] Cystic fibrosis

Epithelial functions, including rhodamine efflux and CFTR-mediated fluid secretion, were detected. Data showed that functionally impaired hPSC-derived cholangiocytes from cystic fibrosis patients are rescued by CFTR correctors

Collagen/Matrigel mixture [147] Pancreas Diabetes mellitus

The hPSC-ECs were demonstrated to express pancreatic endocrine hormones and EC clusters started insulin secretion in response to glucose stimulus and potassium channel inhibition in vitro None [150] Cystic fibrosis Acinar and ductal progeny were modeled

Matrigel embedding [152] 

Matrigel embedding [174] Hirschsprung disease

The model studied the cellular and molecular pathogenesis of Hirschsprung disease with a mutation in the PHOX2B gene Matrigel embedding [166] H5N6/39715, and H1N1pdm/415742). They were comparable to human ex vivo bronchus cultures and could serve as an alternative experimental model for studying virus tropism and replication competence to assess the pandemic threats of novel influenza viruses [134] . Porotto et al. demonstrated the successful spread of human parainfluenza virus 3 (HPIV3) in lung organoids derived from hPSCs by infecting AT2 cells in the organoids. Using this model, viral evolution and pathogenesis could be simulated, and essential features of human viral infection could be mimicked in these organoids [125] . Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and pneumonia in children younger than 1 year of age in the United States [121] . Lung bud organoids (LBO) generated from hPSCs were used to model lung parenchyma in the second trimester of gestation in human life. The LBOs were composed of mesoderm and pulmonary endoderm cells that developed into branching airways and early alveolar structures upon xenotransplantation or in a Matrigel 3D culture. The analysis of expression and structural features showed that the branching structures were similar to those observed in the second trimester of human gestation. Two days after the infection of LBOs with RSV, infected cells began to swell, detach, and shed into the organoid lumen [126] . In summary, lung organoids represent state-of-the-art platforms to model lung diseases by recapitulating the interactions between host pulmonary cells, immune cells, the ECM, and invading pathogens. Therefore, they consist powerful tools for modeling human lung diseases, drug screening, and toxicity assays.

Liver diseases are among the most common pathologies of the digestive tract, occurring at increasing frequencies due to alcohol abuse, obesity, viral infections, and the lack of physical activity [127] . Fatty liver and viral hepatitis are two common liver diseases leading to cirrhosis and ultimately liver cancer. The liver is a complex metabolic and detoxifying organ with a sophisticated inner microenvironment; therefore, generating accurate models of the diseased liver for exploring treatment options has been challenging [128] [129] [130] (Table 3) .

Liver fibrosis is characterized by excessive ECM deposition, which leads to scarred tissue and eventually organ failure. Hepatic stellate cells (HSCs), the major collagenproducing cells of the liver, are the main cell types involved in liver fibrosis following injury from metabolic, cholestatic, viral, or toxic causes. When hepatocytes are damaged, a cascade of events is triggered activating quiescent HSCs into a myofibroblastic (activated) HSC state [131] . Leite et al. developed a 3D co-culture of primary stellate cells and the HepaRG cell line. Following repeated exposure to the pro-fibrotic compounds for 14 days, including allyl alcohol and methotrexate, hepatic organoids displayed fibrotic features, such as HSC activation, collagen secretion, and ECM deposition [132] . Another research consortium developed a liver fibrosis model using highly reproducible iPSCsderived HSCs that remained quiescent when maintained as 3D spheroids with HepaRG, but became activated to secrete pro-collagen in response to hepatocyte toxicity, thus recapitulating in vivo human HSCs function [133] .

Non-alcoholic fatty liver disease (NAFLD), a complex condition characterized by steatosis, is multifactorial in etiology with many identified environmental and genetic risk factors. NAFLD patients may develop a more severe nonalcoholic steatohepatitis (NASH) disease that can further progress to liver fibrosis and cirrhosis [134] . Kruitwagen et al. established a liver steatosis organoid model using adult liver stem cells from mouse, human, dog, and cat [135] . When fatty acids were added to the culture media, the liver stem cells absorbed the fat, leading to lipid accumulation. The analysis of genes central to fat accumulation, including SREBF1, CPT1A and PPARG, revealed that liver organoids from dog and human cells exhibited the distinct regulation of lipid metabolic pathways [135] . However, pro-fibrotic or inflammatory cell types are absent in culture conditions, limiting the ability to fully model liver diseases in vitro. Ouch et al. used 11 pluripotent stem cell lines from healthy and sick individuals to differentiate into multicellular human liver organoids composed of hepatocyte-like cells, hepatic stellate-like cells, and Kupffer-like cells. The organoids were incubated with free fatty acids to induce steatosis and fibrosis [136] , which led to the increased secretion of IL-6, TNFα, and IL-8 compared to untreated organoids. Moreover, the authors used patient-derived iPSCs to create organoid models of Wolman disease, an inherited disorder, and established that the organoids were capable of stipulating many of the clinical disease features. These patient-derived organoids were treated with FGF19, which increased the survival rate of the cultured system and reduced lipid accumulation, ROS production, and stiffening [136] . A recent organoid model was developed by Pingitore et al., which is based on cells homozygous for the PNPLA3 I148M sequence variant, the most vital genetic determinant of NAFLD. Hepatocyte (HepG2) and hepatic stellate (LX-2) cell lines were incubated with free fatty acids, which resulted in fat accumulation (steatosis) and collagen secretion (fibrosis). A physiological phenotype was restored by incubating the organoids with anti-steatotic and anti-fibrotic drugs, including liraglutide and elafibranor [137] .

Alcoholic liver diseases (ALDs) are among the major causes of chronic liver illnesses affecting many people worldwide, and leading to irreversible fibrosis and cirrhosis. Wang et al. developed liver organoids from hESCs cocultured with MSC, and treatment of the organoids with ethanol successfully induced numerous ALD-associated pathophysiological changes, including oxidative stress, steatosis, release of inflammatory mediators, and fibrosis [138] .

Chronic viral hepatitis has a high incidence in the general population; approximately 2 billion people are infected with HBV worldwide, leading to significant morbidity and mortality [139] . Several models have been developed for HBV infection, but none display individualized genetic backgrounds. Primary human hepatocytes (PHHs) are a valuable model for HBV infection studies due to the high expressions levels of NTCP, a receptor used by HBV to enter hepatocytes [140] ; PHHs, however, have limited supply and are of variable quality [141] . A recent study revealed that PHHs could be efficiently converted into hepatic progenitorlike cells (HepLCs) by exploiting relevant developmental signals, such as the NAD+-dependent deacetylase SIRT1 signaling. Organoids formed using HepLCs were found to express NTCP, and molecular data suggested the presence of HBV transcriptome in host cells upon transfection, corroborating the use of this organoid model for exploring HPV infection [142] . Liver organoids have also been generated from a co-culture of iPSC-derived hepatocytes, mesenchymal stem cells (MSCs), and human umbilical vein endothelial cells (HUVEC). Interestingly, these liver organoids expressed high levels of NTCP and maintained long-term HBV propagation, which was associated with hepatic dysfunction [143] .

Inherited liver diseases are a group of metabolic and genetic defects that occur due to the failure of enzyme/ transport proteins involved in specific metabolic pathways in the liver [144] . Alpha-1 antitrypsin (A1AT) deficiency is a hereditary condition that leads to chronic obstructive pulmonary disease and chronic liver disease; the most common related disorders are Alagille syndrome and cystic fibrosis (CF). Alagille syndrome is caused by mutations in the Notch-signaling pathway, which results in partial to complete biliary atresia.

Several studies developed patient-derived hepatocytes and cholangiocytes to investigate and model genetic liver diseases [136] . Huch et al. employed Lgr5 + liver stem cells to construct organoid-based inherited disease models using biopsies from patients with A1AT deficiency or Alagille syndrome. A1AT accumulated in these organoids similarly to the original biopsies from patients. The results also confirmed that the aggregation of A1AT protein blocks elastase activity in A1AT organoids. Organoids derived from an Alagille syndrome patient reproduced the structural duct defects in the biliary tree of such patients, and this study was the first model of human 3D system generated to study the syndrome. Homologous recombination by CRISPR/ Cas9 was able to successfully repair the associated genetic defect [145] . Guan et al. also developed an in vitro model system to study the JAG1 mutation in Alagille syndrome using iPSCs differentiated into 3D human hepatic organoids. The generated organoids were composed of hepatocytes and cholangiocytes organized into epithelial cells surrounding the lumina of bile duct-like structures [146] . Ogawa et al. recently developed a cystic fibrosis model and corrected the CFTR (cystic fibrosis transmembrane conductance regulator) misfolding and translocation in cell membranes in patient-derived cholangiocyte organoids (hPSC-derived cholangiocytes) by using inhibitors to decrease misfolding and promote protein stabilization [147] .

In conclusion, although the current differentiation protocols in the development of hepatic organoids are not promising, it is essential to continue developing in vitro models to study disease pathophysiology and to conduct preclinical pharmaco-toxicological studies. This may be achieved through the adaptation of media composition and the application of ECM in organoid culture systems.

In general, the pancreas is a composite gland containing an exocrine compartment of acinar and ductal cells and an endocrine compartment of alpha, beta, gamma, epsilon, and PP (pancreatic polypeptide) cells organized within 'Langerhans islets' [148] . Numerous diseases arising from defects in the different compartments affect the pancreas, including diabetes mellitus (DM), CF, and pancreatic adenocarcinoma ( Table 3) . DM is the most frequent endocrine disease, which is characterized by hyperglycemia, and is classically categorized in 2 types: type 1 is an autoimmune disease in which pancreatic β cells suffer damage, and type 2 is caused by peripheral insulin resistance with insufficient insulin production by pancreatic β cells [149] . Kim et al. developed pancreatic islet-like clusters in vitro from hESCs and iPSCs and demonstrated that cell cultures had glucose-responsive insulin secretion. The hPSC-derived endocrine cells (ECs) were shown to express pancreatic endocrine hormones (insulin, somatostatin, and pancreatic polypeptide) and EC clusters (ECCs) started insulin secretion in response to glucose stimulus and potassium channel inhibition in vitro [150] .

Cystic fibrosis is an inherited disorder that affects multiple organs, including the pancreas, which is typically one of the first affected organs; current knowledge about the pathophysiological changes in the pancreas during CF is limited [151] . Hohwieler et al. designed an approach to generate pancreatic organoids from hPSCs that resembled acinar and ductal progeny. Following the same approach, iPSC-derived organoids from CF patients were also generated, which exhibited pancreatic cell specification and recapitulated the key developmental events in vitro. The CFTR mutated pancreatic organoids proved to be a promising reliable platform to reflect the patient phenotype in the functional swelling assay, and thus are potential disease models for individualized drug testing in pancreatic tissue [152] .

Gastric diseases, including digestive ulcer disease and gastric cancer, affect 10% of the world's population. Most of them are caused by chronic Helicobacter pylori infection [153] . Gastric organoids (GO) can be derived from iPSCs as well as adult stem cells from the corpus and antropyloric epithelium [154] (Table 3) . McKracken et al. established hiPSC-GO cultures to identify the unique signaling mechanisms that regulate early endoderm patterning and gastric endocrine cell differentiation upstream to NEUROG3. Moreover, they modeled the pathophysiological response of the gastric epithelium to H. pylori and showed that H. pylori infection caused the rapid association of virulence factor CagA with the c-Met receptor, leading to the activation of signaling and stimulation of epithelial proliferation [155] . Bartfeld et al. also generated GOs from surgical samples of human gastric corpus and provided sufficient evidence to demonstrate that stem cells existed in adult human gastric tissue. The organoids contained four different cells of the stomach: pit mucous cells, gland mucous cells, chief cells, and enteroendocrine cells. The GOs were used to analyze the primary response of the human epithelium to H. pylori and revealed that the infection induced robust NF-kB activation [156] . Numerous studies have reported on the pathogenesis of H. pylori infection using organoid models for validating the established hypothesis, and discovering new mechanisms [157] [158] [159] [160] .

In the intestine, several signaling pathways, including Wnt, Notch, fibroblast growth factor (FGF)/epidermal growth factor (EGF), and bone morphogenetic protein (BMP)/Nodal signaling, are essential during tissue development, adult homeostasis, and repair following injury [161, 162] . The luminal surface of the mammalian intestine consists of a single layer of self-assembling epithelial cells. This epithelium is divided into two regions: villus and crypt. The latter contains intestinal stem cells with high expression of LGR5, a protein involved in WNT signaling. Thus, LGR5 + cells represent a reliable source to generate organoids [163] . Intestinal organoids (IOs) have been developed from different sources, including postnatal and adult epithelial cells [164] , adult intestinal stem cells (known as 'enteroids') [165] , and PSC-derived organoids [166] (Table 3) .

The apical part of the epithelial surface of the lumen is the main attachment site for many intestinal pathogens. The generation of IOs offers a tool for studying host-microbe interactions [167] . The mechanisms of secretory diarrhea caused by Vibrio cholerae have been studied using organoid models from human duodenal and jejunal biopsies [168] . HiPSC-derived organoids have also been used to explore the interactions between human intestinal epithelium and enteric pathogens. Forbester et al. developed human intestinal organoids (HIOs) from hiPSCs to investigate the interaction of Salmonella enterica serovar Typhimurium with the human intestinal epithelium; the authors demonstrated that, after exposing organoids to the bacteria by microinjection into the organoid lumen, the cytokine expression pattern was changed and S. e. Typhimurium attacked the epithelial barrier [169] . These results show that HIOs can recapitulate human tissue responses to bacterial pathogens, including the internalization of bacteria, upregulated secretion of mucus, epithelial barrier interruption, and prompted pro-inflammatory cytokine expression [170] [171] [172] .

In other diseases such as CF, IOs generated from patientderived primary intestinal stem cells accurately recapitulated the CF phenotype, and CRISPR/Cas9-mediated gene editing was able to repair the CFTR mutation and restore the functional phenotypes [173] . Studies on intestinal fibrosis modeling have been used with respect to Crohn's disease (CD). Stem cell-derived HIOs have been developed as a model of fibrosis in CD using TGF-β to induce fibrosis. Treatment with spironolactone, an anti-fibrotic drug, was able to reverse fibrosis caused by TGF-β induction [174] . The enteric nervous system (ENS) is the intrinsic nervous system of the bowel that regulates many gut functions, such as motility, secretion, and epithelial permeability. The congenital absence of this system within the bowel results in Hirschsprung disease [175] . HIOs have been generated to model this disorder; these HIOs comprised functional ENS derived from human PSCs differentiated to form neural crest cells. ENS-containing HIOs were able to form neuroglial structures and had an electromechanical coupling that regulated waves of propagating contraction. This model was used to study the cellular and molecular pathogenesis of Hirschsprung's disease with a mutation in the PHOX2B gene [166] .

On the whole, current technologies with multiple cocultured cells and strategies for rebuilding culture microenvironments need to be improved. More advanced culture media and improved ECM can provide the possibility to gain deeper insights into interactions between GI epithelial cells and microbiota, which constitutes a high-priority research field.

Organoids are powerful tools to overcome many of the failures inherent to current in vitro or animal systems, and have the potential to significantly expand our understanding of the pathogenic mechanism of numerous diseases. They have the capacity to self-organize and form complex structures making them ideal in vitro platforms for disease modeling and drug screening; however, many obstacles remain in the technology that need to be addressed in future work. Specifically, the size of all organoids developed to date is limited by the diffusion distance restriction due to the lack of vascular structures (i.e., blood vessels). Strategies such as vascularization by co-culturing with endothelial cells or engineering approaches may help to overcome this obstacle [176] (Box 3). Some organoid models are insufficient and slow-maturing, thus limiting the modeling of later developmental disease stages, with this issue more typical of retinal and cerebral organoids and thicker tissues such as the brain that may undergo necrosis in the organoid interior. Growing the organoids by transplantation may be a solution to this hurdle. In multi-organ individuals like humans, each organ is involved in synchronous and multiple interactions with all other organ systems. Thus, modeling the interactions between ecto-, meso-, and endoderm tissues during development may be a promising approach to better recapitulate the organ system interactions typical of in vivo organisms. Combining organoids into assembloids can be used to model similar aspects of cell-cell interactions and connectivity between regions to those between human body tissues. Koike et al. generated a multi-organ system that structurally and functionally integrates hepato-biliarypancreatic organ domains, and that was developed at the foregut-midgut boundary [177] . Interactions with other cells and ECM components are critical aspects of organoid models. Tissue engineering is an ever-evolving approach to using ECM and other synthetic cell-instructive matrices in composite organoids [178] (Fig. 4) . However, we are far from the exact models of real organs, which necessitates considerable improvement in this field. The ultimate goal of organoid technologies will be to harness the control of amazing selforganizing abilities of cells for our own benefit and apply them for cell replacement, whole-organ transplantation, and drug screening approaches.

Given the incredible successes achieved so far, the organoid field faces many limitations hindering its broader application in disease modeling. For example, the lack of supportive vasculature for increased perfusion is highly critical. Vasculature not only plays an important role in many physiological regulations, but blood vessels are also known to promote signal transduction between cell-cell and cellmatrix, with their main function of transporting nutrients, oxygen, and remove wastes [179] . By incorporating vasculature into organoids, the size and duration organoid culture performance could be significantly increased. This might be crucial for organoids to mimic real organs [179] . Recently, studies have progressively focused on developing vascularized organoids with different approaches ranging from co-culture with endothelial cells, to co-differentiation with mesodermal progenitors and in vivo transplantation, etc. In this regard, successful experiments were able to establish brain, liver, and kidney organoids [176, [179] [180] [181] [182] . Among them, sufficient perfusion was achieved in organoids through in vivo transplantation because of the appropriate microenvironment and niche. Currently, scientists' attempts continue to find a better way to vascularize organoids, which will help to construct more accurate disease models. Eventually, as an improved technology, organoid technology combined with high-tech approaches such as microfluidic engineering or bio-printing techniques could lead to fully in vitro vascularized organoids, acting as more reliable platforms to further expand our understanding of diseases and facilitate drug discovery through advanced modeling Fig. 4 View of organoid challenges and perspectives. The schematic illustration represents organoid technology challenges including slow maturation, lack of ECM, vascularization, and ecto-meso-endoderm interactions with a foreseeable solution to overcome these weaknesses by transplantation, tissue engineering, co-culture, and assembloids

The hope and the hype of organoid research

Tissue engineering in liver regenerative medicine: insights into novel translational technologies

Human organoids: a new dimension in cell biology

Cystic organoid teratoma: (report of a case)

Modeling development and disease with organoids

Generation of transplantable three-dimensional hepatic-patch to improve the functionality of hepatic cells in vitro and in vivo

Application of cancer organoid model for drug screening and personalized therapy

Disease modeling in stem cellderived 3D organoid systems

Disease modelling in human organoids

Personalized cancer medicine: an organoid approach

Human organoids: model systems for human biology and medicine

Organoid culture: applications in development and cancer

Organoid cultures derived from patients with advanced prostate cancer

Prospective derivation of a living organoid biobank of colorectal cancer patients

A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis

Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

Patient-derived colorectal cancer organoids upregulate revival stem cell marker genes following chemotherapeutic treatment

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics

Human gastric cancer modelling using organoids

A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening

Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis

A patient-derived glioblastoma organoid model and biobank recapitulates inter-and intra-tumoral heterogeneity

Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours

Organoid models of human and mouse ductal pancreatic cancer

Pancreatic cancer organoids recapitulate disease and allow personalized drug screening

Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression

Human primary liver cancer-derived organoid cultures for disease modeling and drug screening

A living biobank of breast cancer organoids captures disease heterogeneity

Tumor evolution and drug response in patient-derived organoid models of bladder cancer

Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening

Long-term expanding human airway organoids for disease modeling

Patientderived organoids model treatment response of metastatic gastrointestinal cancers

Organoids-preclinical models of human disease

Engineering a model to study viral infections: bioprinting, microfluidics, and organoids to defeat Coronavirus Disease 2019 (COVID-19)

An update to "novel therapeutic approaches for treatment of COVID-19

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinicalgrade soluble human ACE2

Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids

Identification of drugs blocking SARS-CoV-2 infection using human pluripotent stem cell-derived colonic organoids

Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses

Novel therapeutic approaches for treatment of COVID-19

Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov

SARS-CoV-2 productively infects human gut enterocytes

In vitro differentiation of transplantable neural precursors from human embryonic stem cells

Neural differentiation from human embryonic stem cells in a defined adherent culture condition

Selforganized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals

Modeling human cortical development in vitro using induced pluripotent stem cells

Analysing human neural stem cell ontogeny by consecutive isolation of Notch active neural progenitors

Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses

Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord

Differentiation of embryonic stem cells into neural cells on 3D poly (D, L-lactic acid) scaffolds versus 2D cultures

Cerebral organoids model human brain development and microcephaly

CPAP promotes timely cilium disassembly to maintain neural progenitor pool

Recapitulating cortical development with organoid culture in vitro and modeling abnormal spindle-like (ASPM related primary) microcephaly disease

Induction of expansion and folding in human cerebral organoids

FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders

CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells

DISC1 regulates neurogenesis via modulating kinetochore attachment of Ndel1/Nde1 during mitosis

MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling

Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation

Human iPSC-derived cerebral organoids model cellular features of lissencephaly and reveal prolonged mitosis of outer radial glia

An organoidbased model of cortical development identifies non-cell-autonomous defects in Wnt signaling contributing to Miller-Dieker syndrome

The Brazilian Zika virus strain causes birth defects in experimental models

Zika virus impairs growth in human neurospheres and brain organoids

Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure

Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3

Zika virus alters DNA methylation of neural genes in an organoid model of the developing human brain

High-content screening in hPSC-neural progenitors identifies drug candidates that inhibit Zika virus infection in fetal-like organoids and adult brain

Self-organized cerebral organoids with human-specific features predict effective drugs to combat Zika virus infection

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

25-Hydroxycholesterol protects host against Zika virus infection and its associated microcephaly in a mouse model

Zika virus cell tropism in the developing human brain and inhibition by azithromycin

Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells

Genetic ablation of AXL does not protect human neural progenitor cells and cerebral organoids from Zika virus infection

Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses

The use of brain organoids to investigate neural development and disease

Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer's disease phenotypes

Inhibition of p25/Cdk5 attenuates tauopathy in mouse and iPSC models of frontotemporal dementia

Modeling amyloid beta and tau pathology in human cerebral organoids

A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease

Modeling G2019S-LRRK2 sporadic Parkinson's disease in 3D midbrain organoids

Modeling Parkinson's disease in midbrain-like organoids

Use of 3D organoids as a model to study idiopathic form of Parkinson's disease

Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson's disease modeling

Anatomical and physiological development of the human inner ear

Molecular mechanisms of inner ear development

Generation of inner ear sensory epithelia from pluripotent stem cells in 3D culture

Defective Tmprss3-Associated hair cell degeneration in inner ear organoids

Three-dimensional retinal organoids facilitate the investigation of retinal ganglion cell development, organization and neurite outgrowth from human pluripotent stem cells

Self-organizing optic-cup morphogenesis in three-dimensional culture

Self-formation of optic cups and storable stratified neural retina from human ESCs

Identification and correction of mechanisms underlying inherited blindness in human iPSC-derived optic cups

Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients

Arl3 and RP2 regulate the trafficking of ciliary tip kinesins

Patient-specific retinal organoids recapitulate disease features of late-onset retinitis pigmentosa

AB0189 3d skin organoid mimicking systemic sclerosis generated by patient-derived induced pluripotent stem cells: 'disease in a dish' and development of animal model

Functional and proteomic analysis of a full thickness filaggrin-deficient skin organoid model

Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies

HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy

Human engineered cardiac tissues created using induced pluripotent stem cells reveal functional characteristics of BRAF-mediated hypertrophic cardiomyopathy

Integrative analysis of PRKAG2 cardiomyopathy iPS and microtissue models identifies AMPK as a regulator of metabolism, survival, and fibrosis

Development of a human cardiac organoid injury model reveals innate regenerative potential

Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing

Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

Gene-edited human kidney organoids reveal mechanisms of disease in podocyte development

Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease

3D organoidderived human glomeruli for personalised podocyte disease modelling and drug screening

Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network

Organoids from nephrotic disease-derived iPSCs identify impaired NEPHRIN localization and slit diaphragm formation in kidney podocytes

Patient-iPSCderived kidney organoids show functional validation of a ciliopathic renal phenotype and reveal underlying pathogenetic mechanisms

Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy

Gene-edited human kidney organoids reveal mechanisms of disease in podocyte development

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinicalgrade soluble human ACE2

Generation of lung organoids from human pluripotent stem cells in vitro

Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung

Development of a three-dimensional bioengineering technology to generate lung tissue for personalized disease modelling

Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells

Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injury

Human organoid cultures: transformative new tools for human virus studies

Modelling Cryptosporidium infection in human small intestinal and lung organoids

Differentiated human airway organoids to assess infectivity of emerging influenza virus

Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures

Authentic Modeling of human respiratory virus infection in human pluripotent stem cell-derived lung Organoids

A threedimensional model of human lung development and disease from pluripotent stem cells

Liver tissue engineering: challenges and opportunities

Organoids of liver diseases: From bench to bedside

New platforms for drug screening and toxicology: necessity or need?

Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture

Bioengineered 3D models to recapitulate tissue fibrosis

Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro

Generation of hepatic stellate cells from human pluripotent stem cells enables in vitro modeling of liver fibrosis

Advances in generating liver cells from pluripotent stem cells as a tool for modelling liver diseases

Longterm adult feline liver organoid cultures for disease modeling of hepatic steatosis

Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids

Human multilineage 3D spheroids as a model of liver steatosis and fibrosis

Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury

Update on global epidemiology of viral hepatitis and preventive strategies

In vitro experimental infection of primary human hepatocytes with hepatitis B virus

Towards improved hepatocyte cultures: progress and limitations

Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens

Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells

Genetic diseases that predispose to early liver cirrhosis

Long-term culture of genome-stable bipotent stem cells from adult human liver

Human hepatic organoids for the analysis of human genetic diseases

Directed differentiation of cholangiocytes from human pluripotent stem cells

Pancreatic progenitors and organoids as a prerequisite to model pancreatic diseases and cancer

The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives

Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo

Cystic fibrosis genetics: from molecular understanding to clinical application

Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling

Helicobacter pylori virulence factors in gastric carcinogenesis

Lgr5+ ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro

Modelling human development and disease in pluripotent stem-cell-derived gastric organoids

In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection

CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation

Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells

Increased programmed death-ligand 1 is an early epithelial cell response to Helicobacter pylori infection

A novel gastric spheroid co-culture model reveals chemokine-dependent recruitment of human dendritic cells to the gastric epithelium

Disease modelling in human organoids

Engineering biomimetic intestinal topological features in 3D tissue models: retrospects and prospects

Stem cells, self-renewal, and differentiation in the intestinal epithelium

Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system

Gut organoids: mini-tissues in culture to study intestinal physiology and disease

Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract

Interaction of Salmonella enterica serovar Typhimurium with intestinal organoids derived from human induced pluripotent stem cells

Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coli

Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function

Human Clostridium difficile infection: altered mucus production and composition

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients

Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs

Hirschsprung disease-integrating basic science and clinical medicine to improve outcomes

Vascularized and functional human liver from an iPSC-derived organ bud transplant

Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary

Recent advances in chemically defined and tunable hydrogel platforms for organoid culture. Manufacturing

Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature

Vascularized organoids: a more complete model

Flow-enhanced vascularization and maturation of kidney organoids in vitro

Engineering of human brain organoids with a functional vascular-like system

This study was financially supported by the National Cancer Control Charity Foundation (Registration Number